Ultragenyx Pharmaceutical Inc. (RARE): Price and Financial Metrics


Ultragenyx Pharmaceutical Inc. (RARE)

Today's Latest Price: $44.43 USD

0.11 (0.25%)

Updated Mar 31 6:55pm

Add RARE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 337 in Biotech

See all "A" rated Strong Buy stocks

RARE Stock Summary

  • For RARE, its debt to operating expenses ratio is greater than that reported by merely 10.73% of US equities we're observing.
  • RARE's price/sales ratio is 23.16; that's higher than the P/S ratio of 95.38% of US stocks.
  • As for revenue growth, note that RARE's revenue has grown 101.41% over the past 12 months; that beats the revenue growth of 94.42% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Ultragenyx Pharmaceutical Inc are RGNX, ASMB, FPRX, MEIP, and PZG.
  • Visit RARE's SEC page to see the company's official filings. To visit the company's web site, go to www.ultragenyx.com.
RARE Daily Price Range
RARE 52-Week Price Range

RARE Stock Price Chart More Charts


RARE Price/Volume Stats

Current price $44.43 52-week high $74.50
Prev. close $44.32 52-week low $31.99
Day low $42.57 Volume 483,800
Day high $44.88 Avg. volume 585,679
50-day MA $52.02 Dividend yield N/A
200-day MA $49.77 Market Cap 2.57B

Ultragenyx Pharmaceutical Inc. (RARE) Company Bio


Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company was founded in 2010 and is based in Novato, California.


RARE Latest News Stream


Event/TimeNews Detail
Loading, please wait...

RARE Latest Social Stream


Loading social stream, please wait...

View Full RARE Social Stream

RARE Price Returns

1-mo -22.15%
3-mo 3.06%
6-mo -0.20%
1-year -38.83%
3-year -34.45%
5-year -28.57%
YTD 4.03%
2019 -1.77%
2018 -6.25%
2017 -34.03%
2016 -37.32%
2015 155.65%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9174 seconds.